Rhoda Au
Profiles

Rhoda Au, PhD

Professor, Epidemiology - Boston University School of Public Health

Biography

Dr. Au’s research interests are focused on aging and dementia, and include relating cardiovascular risk factors, brain MRI measures, and neuropathology to cognitive performance. She is also interested in merging research and technology as the path toward innovative science.

Other Positions

  • Professor, Anatomy & Neurobiology - Boston University Chobanian & Avedisian School of Medicine
  • Investigator - Framingham Heart Study
  • Member, Evans Center for Interdisciplinary Biomedical Research - Boston University
  • Graduate Faculty (Primary Mentor of Grad Students) - Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences
  • Professor, Medicine - Boston University Chobanian & Avedisian School of Medicine

Education

  • University of California, Riverside, PhD Field of Study: Psychology
  • Boston University, MBA Field of Study: Policy Analysis and Management
  • Pomona College, BA Field of Study: Psychology

Publications

  • Published on 4/23/2025

    De Anda-Duran I, Hwang PH, Drabick DA, Andersen SL, Au R, Libon DJ. Neuropsychological phenotypic characteristics in a cohort of community-based older adults: Data from the Framingham Heart Study. J Alzheimers Dis. 2025 Jun; 105(4):1447-1459. PMID: 40267270.

    Read At: PubMed
  • Published on 4/22/2025

    Ding H, Madan S, Searls E, McNulty M, Low S, Li Z, Ho K, Rahman S, Igwe A, Popp Z, Hwang PH, De Anda-Duran I, Kolachalama VB, Mez J, Alosco ML, Thomas RJ, Au R, Lin H. Exploring nightly variability and clinical influences on sleep measures: insights from a digital brain health platform. Sleep Med. 2025 Jul; 131:106532. PMID: 40306226.

    Read At: PubMed
  • Published on 4/22/2025

    Libon DJ, Swenson R, Langford DT, Cosentino S, Price CC, Lamar M, Emrani S, Au R, Andersen S, Chen MH, Ashendorf L, Thompson L. Precision neurocognition: An emerging diagnostic paradigm leveraging digital cognitive assessment technology. J Alzheimers Dis. 2025 Apr 22; 13872877251325725. PMID: 40262110.

    Read At: PubMed
  • Published on 4/19/2025

    Yuan J, Tao Q, Au R. Reply to "Gender Differences and Vascular Risk: Unveiling New Pathways for Dementia Prevention". Ann Neurol. 2025 Jun; 97(6):1224-1225. PMID: 40251898.

    Read At: PubMed
  • Published on 4/14/2025

    Castro-Aldrete L, Einsiedler M, Novakova Martinkova J, Depypere H, Alvin Ang TF, Mielke MM, Sindi S, Eyre HA, Au R, Schumacher Dimech AM, Dé A, Szoeke C, Tartaglia MC, Santuccione Chadha A. Alzheimer disease seen through the lens of sex and gender. Nat Rev Neurol. 2025 May; 21(5):235-249. PMID: 40229578.

    Read At: PubMed
  • Published on 4/1/2025

    Ding H, Lyu C, Karjadi C, Sunderaraman P, Young CB, Mormino EC, Low S, Devine S, Gifford K, Au R, Lin H. Association of the digital clock drawing test with amyloid and tau PET biomarkers in low age risk adults. Sci Rep. 2025 Apr 01; 15(1):11104. PMID: 40169870.

    Read At: PubMed
  • Published on 4/1/2025

    Nevler N, Niehoff D, Gleixner AM, Dodge S, Vogel AP, Hill DL, Ducharme S, Staffaroni AM, Yunusova Y, Au R, Macwhinney B, Wong B, Parish-Morris J, Geronimo A, Hansen BJ, Beattie ZT, Stephenson DT, Boxer AL, Dacks P, Rohrer JD. Developing digital health technologies for frontotemporal degeneration. Alzheimers Dement. 2025 Apr; 21(4):e70082. PMID: 40285380.

    Read At: PubMed
  • Published on 3/28/2025

    Labonte J, Sugarman MA, Pettway E, Zetterberg H, Blennow K, Ashton NJ, Karikari TK, Aparicio HJ, Frank B, Tripodis Y, Martin B, Palmisano JN, Steinberg EG, Simkin I, Farrer LA, Jun GR, Turk KW, Budson AE, O'Connor MK, Au R, Goldstein LE, Stern RA, Stein TD, McKee AC, Qiu WQ, Mez J, Banks SJ, Alosco ML. Sex differences on tau, astrocytic, and neurodegenerative plasma biomarkers. J Alzheimers Dis. 2025 May; 105(2):443-452. PMID: 40151917.

    Read At: PubMed
  • Published on 3/17/2025

    Jasodanand VH, Kowshik SS, Puducheri S, Romano MF, Xu L, Au R, Kolachalama VB. AI-driven fusion of neurological work-up for assessment of biological Alzheimer's disease. medRxiv. 2025 Mar 17. PMID: 40166530.

    Read At: PubMed
  • Published on 3/11/2025

    Borson S, Au R, Chodos AH, Gandy S, Jain H, Alagor A, Cohn K, Kerwin DR, Mintzer J, Monroe S, Robinson D, Mielke MM, Wilcock DM. Opportunities to encourage adoption of a biomarker-enabled care pathway for Alzheimer's in primary care. Alzheimers Dement (Amst). 2025; 17(1):e70095. PMID: 40071061.

    Read At: PubMed

News & In the Media